Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeNicholas McGranahan, Charles Swanton, Thomas B.K. Watkins et al.|Science|2016Cited by 3.1k
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancerGerard Walls, Alastair Greystoke, Jamie B. Oughton et al.|Clinical and Translational Radiation Oncology|2020Cited by 34
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assayFrancesco Orlando, Crispin T. Hiley, Alessandro Romanel et al.|NAR Cancer|2022Cited by 17
P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLCA. Horne, A. Greystoke, Sarah Brown et al.|Journal of Thoracic Oncology|2023Cited by 2
77P Experience pooling control arms within a complex phase I drug-radiotherapy (RT) platform trialJamie B. Oughton, Sarah Brown, J. Kendall et al.|ESMO Open|2024Cited by 0